NCT06244173Completed
Clinical and Laboratory Parameters of Myelodysplastic Syndromes at Upper Egypt
Source: ClinicalTrials.gov · Last updated 6 Feb 2024
Brief summary (registry, in English)
The aim of our study is to assess clinical \& laboratory parameters of adult Egyptian myelodysplastic syndrome patients in upper Egypt, its correlation with disease-free survival, overall survival (OS) and acute leukemia transformation.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 100 (actual)
- First submitted
- 4 Oct 2023
- Start date
- 1 Jun 2017
- Primary completion date
- 1 Nov 2023
- Lead sponsor
- Sohag University
- Diseases
- Myelodysplastic syndromes
- NCT number
- NCT06244173
What you commit to
- Study type: Observational
- Participants enrolled: 100
- From 1 Jun 2017 to the primary completion date, 1 Nov 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- MDS on top of AML
Who the study is looking for
- De novo MDS according to WHO criteria diagnosis 2016
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sohag univeristy hospitals Coordinator of this site? Confirm its status | Sohag | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.